Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

about

The NISTmAb Reference Material 8671 lifecycle management and quality plan.The NISTmAb tryptic peptide spectral library for monoclonal antibody characterization.The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability.

P2860

Q50048178-1629065F-CC81-4259-88A9-CBB4BFF7D963 Q50100063-A53B4E9B-AA07-4F51-9029-5EC27C339CA6 Q50146573-18FC66DE-895B-4464-BAEB-8CA54F08634C

P2860

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

Item

http://www.wikidata.org/entity/Q50057241

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@en

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@nl

type

Item

label

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@en

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@nl

prefLabel

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@en

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@nl

P1476

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

@en

P2093

John E Schiel

http://www.w3.org/2001/XMLSchema#string

Trina Mouchahoir

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.

Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product.

Sample preparation for peptide mapping--A pharmaceutical quality-control perspective.

LC-MS/MS peptide mapping with automated data processing for routine profiling of N-glycans in immunoglobulins.

Effect of 'pH' on the rate of asparagine deamidation in polymeric formulations: 'pH'-rate profile.

Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.

Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.

Detecting low level sequence variants in recombinant monoclonal antibodies

Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.

P2888

s00216-018-0848-6

P304

2111-2126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00216-018-0848-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

410

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29411091

http://www.w3.org/2001/XMLSchema#string

P932

5830484

http://www.w3.org/2001/XMLSchema#string

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

about

P2860

P2860

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932